Advertisement Breckenridge, Pharmaceutics enter HRT product agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Breckenridge, Pharmaceutics enter HRT product agreement

Breckenridge has entered into an agreement with Pharmaceutics International to develop and manufacture a generic HRT product.

Breckenridge filed an ANDA with the FDA in early 2006 and expects to receive FDA Approval and market the product in 2007.

Breckenridge says it has an aggressive product development program and looks forward to adding more products to its ANDA portfolio during 2007.